Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Interparfums (IPAR) Common Equity (2016 - 2025)

Historic Common Equity for Interparfums (IPAR) over the last 16 years, with Q3 2025 value amounting to $1.1 billion.

  • Interparfums' Common Equity rose 1211.68% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 1211.68%. This contributed to the annual value of $942.6 million for FY2024, which is 565.76% up from last year.
  • Interparfums' Common Equity amounted to $1.1 billion in Q3 2025, which was up 1211.68% from $1.1 billion recorded in Q2 2025.
  • Interparfums' Common Equity's 5-year high stood at $1.1 billion during Q3 2025, with a 5-year trough of $706.7 million in Q1 2021.
  • Over the past 5 years, Interparfums' median Common Equity value was $849.6 million (recorded in 2023), while the average stood at $858.1 million.
  • Its Common Equity has fluctuated over the past 5 years, first plummeted by 390.2% in 2022, then soared by 2009.44% in 2023.
  • Over the past 5 years, Interparfums' Common Equity (Quarter) stood at $738.3 million in 2021, then increased by 6.75% to $788.1 million in 2022, then rose by 13.2% to $892.2 million in 2023, then rose by 5.66% to $942.6 million in 2024, then increased by 17.17% to $1.1 billion in 2025.
  • Its Common Equity stands at $1.1 billion for Q3 2025, versus $1.1 billion for Q2 2025 and $1.0 billion for Q1 2025.